Charles Schwab Investment Management Inc Brooklyn Immuno Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.48 - $2.03 $30,283 - $128,072
-63,090 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$1.76 - $4.84 $21,552 - $59,270
-12,246 Reduced 16.26%
63,090 $130,000
Q3 2021

Nov 16, 2021
BUY
$8.86 - $17.05 $151,390 - $291,333
17,087 Added 29.33%
75,336 $701,000
Q2 2021

Aug 16, 2021
BUY
$3.75 - $78.5 $218,433 - $4.57 Million
58,249 New
58,249 $1.05 Million

Others Institutions Holding BTX

# of Institutions
1
Shares Held
1.21M
Call Options Held
0
Put Options Held
0
View Full List

About Brooklyn ImmunoTherapeutics, Inc.

BTX Quotes by TradingView
  • Ticker BTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,825,700
  • Description
  • Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...
More about BTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email